Is CareTrust REIT, Inc. (CTRE) Undervalued? Valuation & Fair Price
At $37.41, 3 of the 4 frameworks would pass on CareTrust REIT, Inc. today — Peter Lynch rates it Buy and Warren Buffett, Benjamin Graham, and Phil Town (Rule #1) rate it Avoid. Each model calculates its own fair value and margin of safety; create a free account to see the exact buy price behind every verdict.
CareTrust REIT, Inc.
CTREReal Estate · REIT - Healthcare Facilities · NYSE
$37.41
P/E 24.6×
CareTrust REIT, Inc. operates as a self-managed, publicly traded real estate investment trust. The company specializes in the ownership, acquisition, development, and leasing of various healthcare properties, including skilled nursing facilities, seniors' housing complexes, and other related medical real estate. It maintains a broad, nationwide portfolio of assets, all under long-term net lease agreements with an expanding group of reputable operators. CareTrust REIT is actively pursuing strategic growth across the United States, leveraging both external investments and organic expansion opportunities.
Investor scorecard
How the four investors rate CareTrust REIT, Inc.
3 of 4 frameworks urge caution
Investor model analysis
Details lockedAt $37.41, 3 of 4 frameworks say Avoid
Intrinsic Value (DCF)
Warren Buffett's valuation model · select an investor above to switch
Intrinsic Value
Locked — upgrade to viewBuy Below
Locked — upgrade to viewStrong Buy
Locked — upgrade to viewMargin of Safety
Locked — upgrade to viewUnlock buy targets with a free account
Get startedCreate a free account to see buy targets, full checklists & risk analysis Get started
Insider & congress activity
Are insiders buying CTRE?
Over recent SEC Form 4 filings, CTRE insiders bought $0 and sold $1.0M of stock across 1 open-market trade. Insiders sell for many reasons, but they buy for one.
| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| Wagner William MCFO and Treasurer | Sell | 35,000 | $1.0M | Sep 4, 2024 |
Members of Congress have also reported 1 trade in CTRE. See the full insider & congress timeline.
Source: SEC Form 4 filings. Open-market buys & sells only. Not investment advice.
See the interactive insider chart & every tradeScenario analysis
Bear, base & bull
Three growth assumptions, three fair values — and where today's price lands
What's working
Key strengths
Identified by Buffett framework analysis
Company financials
5-Year Financials
Income statement highlights — annual, USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $477M | $228M | $199M | $188M | $190M |
| Rev. Growth | +108.8% | +14.9% | +5.9% | -1.4% | — |
| Net Income | $321M | $125M | $54M | -$8M | $72M |
| Net Margin | 67.3% | 54.8% | 27.1% | -4.0% | 37.8% |
| EPS (Diluted) | $1.57 | $0.81 | $0.50 | $-0.08 | $0.50 |
| Free Cash Flow | Locked — upgrade to view | Locked — upgrade to view | Locked — upgrade to view | Locked — upgrade to view | Locked — upgrade to view |
Full analysis included
See the complete picture for CTRE
Exact buy targets, margin of safety, detailed investor checklists, and risk breakdown — all frameworks, all numbers.
Free: 3 analyses/month · Pay per stock: $4.99 · Pro: $19.99/mo
More Real Estate stocks
Educational Use Only · Not Financial Advice
Analysis, scores, valuations, and buy zones are derived from publicly documented investor frameworks (Buffett, Lynch, Benjamin Graham, Phil Town) for learning purposes only. They are not recommendations from licensed financial advisors. Past performance does not guarantee future results. Prices may be delayed up to 15 minutes. Always conduct your own research before making any investment decisions.